跳至主要内容
临床试验/NCT07180953
NCT07180953已完成4 期

Route of Dexamethasone Administration in iPACK and ACB for Total Knee Replacement: A Randomized Trial

Poznan University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年9月13日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Time to first rescue analgesia

研究概览

简要总结

"The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in iPACK With ACB for Total Knee Arthroplasty" - written in plain language according to ClinicalTrials.gov standards:

The goal of this clinical trial is to learn how the route of dexamethasone administration (either through the vein or nerve block) affects pain and inflammation in people having total knee replacement surgery. All participants will receive two types of nerve blocks before surgery: an iPACK block and an adductor canal block (ACB), which help control pain after the operation.

The main questions the study aims to answer are:

Does injecting dexamethasone into the nerve block reduce pain more effectively than giving it by vein? Which method leads to a lower inflammatory response after surgery? Researchers will compare the two groups to see which route offers better pain relief and less swelling after knee surgery.

Participants will:

Be randomly assigned to receive dexamethasone either in the nerve block or by IV Receive standard care for total knee replacement Rate their pain and have blood tests after surgery to measure inflammation

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
65 Years 至 100 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients scheduled for total knee arthroplasty
  • patients aged >65 and <100 years
  • patients can provide informed consent
  • patients can reliably report symptoms to the research team

排除标准

  • inability to provide first-party consent due to cognitive impairment or a
  • language barrier
  • infection at the site of the regional block,
  • coagulation disorders,
  • immunodeficiency,
  • American Society of Anesthesiologists (ASA) physical status of IV or higher,
  • history of regular steroid medication.

研究组 & 干预措施

Control

Placebo Comparator

iPACK block with ACB

干预措施: NaCl 0.9% (Drug)

iv DEX

Active Comparator

iPACK block with ACB + iv Dexamethasone

干预措施: Dexamethasone 4mg (Drug)

pn DEX

Active Comparator

iPACK block with ACB + perineural Dexamethasone

干预措施: Dexamethasone 4mg (Drug)

结局指标

主要结局

Time to first rescue analgesia

时间窗: Time Frame: 48 hours after surgery

Time to first rescue analgesia

次要结局

  • Total opioid consumption(48 hours after surgery)
  • NRS(48 hours after surgery)
  • NLR(48 hours after surgery)
  • PLR(48 hours after surgery)
  • Quadriceps muscle strength assessed using medical research council scale [range 0:5](48 hours after surgery)
  • Nerve damage(48 hours after surgery)
  • glucose(48 hours after surgery)
  • NRS(4 hours after surgery)
  • NRS(8 hours after surgery)
  • NRS(12 hours after surgery)
  • NRS(24 hours after surgery)
  • NLR(12 hours after surgery)
  • NLR(24 hours after surgery)
  • PLR(12 hours after surgery)
  • PLR(24 hours after surgery)
  • Quadriceps muscle strength assessed using medical research council scale [range 0:5](4 hours after surgery)
  • Quadriceps muscle strength assessed using medical research council scale [range 0:5](8 hours after surgery)
  • Quadriceps muscle strength assessed using medical research council scale [range 0:5](12 hours after surgery)
  • Quadriceps muscle strength assessed using medical research council scale [range 0:5](24 hours after surgery)
  • Nerve damage(12 hours after surgery)
  • Nerve damage(24 hours after surgery)
  • glucose(12 hours after surgery)
  • glucose(24 hours after surgery)

研究者

发起方
Poznan University of Medical Sciences
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Impact of Dexamethasone Route on Pain and... | 临床试验